BioHarvest Sciences (NASDAQ:BHST) Trading 3% Higher – Should You Buy?

BioHarvest Sciences Inc. (NASDAQ:BHST) shares were up 3% during mid-day trading on Tuesday . The stock traded as high as $6.12 and last traded at $6.12. Approximately 12,484 shares changed hands during mid-day trading, an increase of 63% from the average daily volume of 7,662 shares. The stock had previously closed at $5.94.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Maxim Group assumed coverage on shares of BioHarvest Sciences in a report on Wednesday, December 18th. They set a “buy” rating and a $12.00 price objective for the company. HC Wainwright initiated coverage on BioHarvest Sciences in a research note on Friday, December 6th. They issued a “buy” rating and a $14.00 price target for the company.

BioHarvest Sciences Stock Up 3.0 %

The company’s 50-day moving average is $5.58. The stock has a market capitalization of $100.52 million, a price-to-earnings ratio of -4.90 and a beta of 2.27.

Institutional Trading of BioHarvest Sciences

A hedge fund recently bought a new stake in BioHarvest Sciences stock. TD Waterhouse Canada Inc. acquired a new stake in shares of BioHarvest Sciences Inc. (NASDAQ:BHST) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 12,042 shares of the company’s stock, valued at approximately $69,000. TD Waterhouse Canada Inc. owned about 0.07% of BioHarvest Sciences as of its most recent SEC filing.

About BioHarvest Sciences

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.